Toxicology Drug Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030


Report
300 Pages
January 2024
Region: Global
Infinium Global Research
ID: 5933645

The report on the global toxicology drug testing market provides qualitative and quantitative analysis for the period from 2023-2030. The toxicology drug testing market was valued at USD 34.74 billion in 2022 and is expected to reach USD 56.87 billion in 2030, with a CAGR of 5.54% during the forecast period 2023-2030. The study on toxicology drug testing market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2023-2030.

The report on toxicology drug testing market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global toxicology drug testing market over the period of 2023-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global toxicology drug testing market over the period of 2023-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

The advancements in testing technologies drive the growth of the toxicology drug testing market.
The rise in demand for toxicology drug testing in the food and beverage industry propels the growth of the market

2) Restraints

The stringent regulatory requirement associated with toxicology drug testing apparatus and reagents may limit the market growth

3) Opportunities

The increasing investment in r and d activities in new drug development and clinical trials creates lucrative opportunities for market growth.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global toxicology drug testing market is segmented on the basis of testing type, testing method, product, and application.

The Global Toxicology Drug Testing Market by Testing Type

In vivo
In vitro
In silico

The Global Toxicology Drug Testing Market by Testing Method

Mass Spectroscopy
Electron Microscopy
Fluroscence labelling
Immunohistochemistry
Others

The Global Toxicology Drug Testing Market by Product

Instruments
Reagents and Consumable
Animal Models
Software
Others

The Global Toxicology Drug Testing Market by Application

Genotoxicity
Cytotoxicity
ADME
Systemic Toxicity
Immunotoxicity
Others

Company Profiles

The companies covered in the report include

Evotec
Promega Corporation
Agilent Technologies, Inc.
Biorad Laboratories Inc.
Eurofins
DH Life Sciences, LLC.
Intertech Group Plc
Creative Biolabs
Laboratory Corporation of America Holdings
SGS SA

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the toxicology drug testing market.
2. Complete coverage of all the segments in the toxicology drug testing market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global toxicology drug testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Chapter 1. Preface

1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Toxicology Drug Testing Market Highlights
2.2. Toxicology Drug Testing Market Projection
2.3. Toxicology Drug Testing Market Regional Highlights

Chapter 3. Global Toxicology drug testing Market Overview

3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Testing Type
3.4.2. Growth Matrix Analysis by Testing Method
3.4.3. Growth Matrix Analysis by Product
3.4.4. Growth Matrix Analysis by Application
3.4.5. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Toxicology Drug Testing Market

Chapter 4. Toxicology Drug Testing Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Toxicology Drug Testing Market
5.2. Companies Profiles
5.2.1. Evotec
5.2.2. Promega Corporation
5.2.3. Agilent Technologies, Inc.
5.2.4. Biorad Laboratories Inc.
5.2.5. Eurofins
5.2.6. DH Life Sciences, LLC.
5.2.7. Intertech Group Plc
5.2.8. Creative Biolabs
5.2.9. Laboratory Corporation of America Holdings
5.2.10. SGS SA

Chapter 6. Global Toxicology drug testing Market by Testing Type

6.1. In vivo
6.2. In vitro
6.3. In silico

Chapter 7. Global Toxicology drug testing Market by Testing Method

7.1. Mass Spectroscopy
7.2. Electron Microscopy
7.3. Fluroscence labelling
7.4. Immunohistochemistry
7.5. Others

Chapter 8. Global Toxicology drug testing Market by Product

8.1. Instruments
8.2. Reagents and Consumable
8.3. Animal Models
8.4. Software
8.5. Others

Chapter 9. Global Toxicology drug testing Market by Application

9.1. Genotoxicity
9.2. Cytotoxicity
9.3. ADME
9.4. Systemic Toxicity
9.5. Immunotoxicity
9.6. Others

Chapter 10. Global Toxicology drug testing Market by Region 2023-2030

10.1. North America
10.1.1. North America Toxicology Drug Testing Market by Testing Type
10.1.2. North America Toxicology Drug Testing Market by Testing Method
10.1.3. North America Toxicology Drug Testing Market by Product
10.1.4. North America Toxicology Drug Testing Market by Application
10.1.5. North America Toxicology Drug Testing Market by Country
10.1.5.1. The U.S. Toxicology Drug Testing Market
10.1.5.1.1. The U.S. Toxicology Drug Testing Market by Testing Type
10.1.5.1.2. The U.S. Toxicology Drug Testing Market by Testing Method
10.1.5.1.3. The U.S. Toxicology Drug Testing Market by Product
10.1.5.1.4. The U.S. Toxicology Drug Testing Market by Application
10.1.5.2. Canada Toxicology Drug Testing Market
10.1.5.2.1. Canada Toxicology Drug Testing Market by Testing Type
10.1.5.2.2. Canada Toxicology Drug Testing Market by Testing Method
10.1.5.2.3. Canada Toxicology Drug Testing Market by Product
10.1.5.2.4. Canada Toxicology Drug Testing Market by Application
10.1.5.3. Mexico Toxicology Drug Testing Market
10.1.5.3.1. Mexico Toxicology Drug Testing Market by Testing Type
10.1.5.3.2. Mexico Toxicology Drug Testing Market by Testing Method
10.1.5.3.3. Mexico Toxicology Drug Testing Market by Product
10.1.5.3.4. Mexico Toxicology Drug Testing Market by Application
10.2. Europe
10.2.1. Europe Toxicology Drug Testing Market by Testing Type
10.2.2. Europe Toxicology Drug Testing Market by Testing Method
10.2.3. Europe Toxicology Drug Testing Market by Product
10.2.4. Europe Toxicology Drug Testing Market by Application
10.2.5. Europe Toxicology Drug Testing Market by Country
10.2.5.1. Germany Toxicology Drug Testing Market
10.2.5.1.1. Germany Toxicology Drug Testing Market by Testing Type
10.2.5.1.2. Germany Toxicology Drug Testing Market by Testing Method
10.2.5.1.3. Germany Toxicology Drug Testing Market by Product
10.2.5.1.4. Germany Toxicology Drug Testing Market by Application
10.2.5.2. United Kingdom Toxicology Drug Testing Market
10.2.5.2.1. United Kingdom Toxicology Drug Testing Market by Testing Type
10.2.5.2.2. United Kingdom Toxicology Drug Testing Market by Testing Method
10.2.5.2.3. United Kingdom Toxicology Drug Testing Market by Product
10.2.5.2.4. United Kingdom Toxicology Drug Testing Market by Application
10.2.5.3. France Toxicology Drug Testing Market
10.2.5.3.1. France Toxicology Drug Testing Market by Testing Type
10.2.5.3.2. France Toxicology Drug Testing Market by Testing Method
10.2.5.3.3. France Toxicology Drug Testing Market by Product
10.2.5.3.4. France Toxicology Drug Testing Market by Application
10.2.5.4. Italy Toxicology Drug Testing Market
10.2.5.4.1. Italy Toxicology Drug Testing Market by Testing Type
10.2.5.4.2. Italy Toxicology Drug Testing Market by Testing Method
10.2.5.4.3. Italy Toxicology Drug Testing Market by Product
10.2.5.4.4. Italy Toxicology Drug Testing Market by Application
10.2.5.5. Rest of Europe Toxicology Drug Testing Market
10.2.5.5.1. Rest of Europe Toxicology Drug Testing Market by Testing Type
10.2.5.5.2. Rest of Europe Toxicology Drug Testing Market by Testing Method
10.2.5.5.3. Rest of Europe Toxicology Drug Testing Market by Product
10.2.5.5.4. Rest of Europe Toxicology Drug Testing Market by Application
10.3. Asia Pacific
10.3.1. Asia Pacific Toxicology Drug Testing Market by Testing Type
10.3.2. Asia Pacific Toxicology Drug Testing Market by Testing Method
10.3.3. Asia Pacific Toxicology Drug Testing Market by Product
10.3.4. Asia Pacific Toxicology Drug Testing Market by Application
10.3.5. Asia Pacific Toxicology Drug Testing Market by Country
10.3.5.1. China Toxicology Drug Testing Market
10.3.5.1.1. China Toxicology Drug Testing Market by Testing Type
10.3.5.1.2. China Toxicology Drug Testing Market by Testing Method
10.3.5.1.3. China Toxicology Drug Testing Market by Product
10.3.5.1.4. China Toxicology Drug Testing Market by Application
10.3.5.2. Japan Toxicology Drug Testing Market
10.3.5.2.1. Japan Toxicology Drug Testing Market by Testing Type
10.3.5.2.2. Japan Toxicology Drug Testing Market by Testing Method
10.3.5.2.3. Japan Toxicology Drug Testing Market by Product
10.3.5.2.4. Japan Toxicology Drug Testing Market by Application
10.3.5.3. India Toxicology Drug Testing Market
10.3.5.3.1. India Toxicology Drug Testing Market by Testing Type
10.3.5.3.2. India Toxicology Drug Testing Market by Testing Method
10.3.5.3.3. India Toxicology Drug Testing Market by Product
10.3.5.3.4. India Toxicology Drug Testing Market by Application
10.3.5.4. South Korea Toxicology Drug Testing Market
10.3.5.4.1. South Korea Toxicology Drug Testing Market by Testing Type
10.3.5.4.2. South Korea Toxicology Drug Testing Market by Testing Method
10.3.5.4.3. South Korea Toxicology Drug Testing Market by Product
10.3.5.4.4. South Korea Toxicology Drug Testing Market by Application
10.3.5.5. Australia Toxicology Drug Testing Market
10.3.5.5.1. Australia Toxicology Drug Testing Market by Testing Type
10.3.5.5.2. Australia Toxicology Drug Testing Market by Testing Method
10.3.5.5.3. Australia Toxicology Drug Testing Market by Product
10.3.5.5.4. Australia Toxicology Drug Testing Market by Application
10.3.5.6. Rest of Asia-Pacific Toxicology Drug Testing Market
10.3.5.6.1. Rest of Asia-Pacific Toxicology Drug Testing Market by Testing Type
10.3.5.6.2. Rest of Asia-Pacific Toxicology Drug Testing Market by Testing Method
10.3.5.6.3. Rest of Asia-Pacific Toxicology Drug Testing Market by Product
10.3.5.6.4. Rest of Asia-Pacific Toxicology Drug Testing Market by Application
10.4. RoW
10.4.1. RoW Toxicology Drug Testing Market by Testing Type
10.4.2. RoW Toxicology Drug Testing Market by Testing Method
10.4.3. RoW Toxicology Drug Testing Market by Product
10.4.4. RoW Toxicology Drug Testing Market by Application
10.4.5. RoW Toxicology Drug Testing Market by Sub-region
10.4.5.1. Latin America Toxicology Drug Testing Market
10.4.5.1.1. Latin America Toxicology Drug Testing Market by Testing Type
10.4.5.1.2. Latin America Toxicology Drug Testing Market by Testing Method
10.4.5.1.3. Latin America Toxicology Drug Testing Market by Product
10.4.5.1.4. Latin America Toxicology Drug Testing Market by Application
10.4.5.2. Middle East Toxicology Drug Testing Market
10.4.5.2.1. Middle East Toxicology Drug Testing Market by Testing Type
10.4.5.2.2. Middle East Toxicology Drug Testing Market by Testing Method
10.4.5.2.3. Middle East Toxicology Drug Testing Market by Product
10.4.5.2.4. Middle East Toxicology Drug Testing Market by Application
10.4.5.3. Africa Toxicology Drug Testing Market
10.4.5.3.1. Africa Toxicology Drug Testing Market by Testing Type
10.4.5.3.2. Africa Toxicology Drug Testing Market by Testing Method
10.4.5.3.3. Africa Toxicology Drug Testing Market by Product
10.4.5.3.4. Africa Toxicology Drug Testing Market by Application

Companies Mentioned

Evotec
Promega Corporation
Agilent Technologies, Inc.
Biorad Laboratories Inc.
Eurofins
DH Life Sciences, LLC.
Intertech Group Plc
Creative Biolabs
Laboratory Corporation of America Holdings
SGS SA

License	Format	Properties	Price
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€2415EUR$2,500USD£2,004GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€6951EUR$7,195USD£5,767GBP